Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease


Vitamin D insufficiency has been implicated in autoimmunity. ChIP-seq experiments using immune cell lines have shown that vitamin D receptor (VDR) binding sites are enriched near regions of the genome associated with autoimmune diseases.

We aimed to investigate VDR binding in primary CD4+ cells from healthy volunteers.

Methods: We extracted CD4+ cells from nine healthy volunteers. Each sample underwent VDR ChIP-seq.

Our results were analysed in relation to published ChIP-seq and RNA-seq data in the Genomic HyperBrowser. We used MEMEChIP for de novo motif discovery.

25-hydroxyvitamin D levels were measured using liquid chromatography-tandem mass spectrometry and samples were divided into vitamin D sufficient (VD>75 nmol/L) and insufficient (VD<75 nmol/L).

Results: We found that the amount of VDR binding is correlated with the serum level of 25-hydroxyvitamin D (r=0.92, p=0.0005). In vivo VDR binding sites are enriched for autoimmune disease associated loci, especially when vitamin D levels (VD) were sufficient (VD>75: 3.13-fold, p<0.0001; VD<75: 2.76-fold, p<0.0001; VD>75 enrichment vs.

VD<75 enrichment: p=0.0002). VDR binding was also enriched near genes associated specifically with T-regulatory and T-helper cells in the VD>75 group.

MEME ChIP did not identify any VDR-like motifs underlying our VDR ChIP-seq peaks.

Conclusion: Our results show a direct correlation between in vivo 25-hydroxyvitamin D levels and the number of VDR binding sites. Our study further implicates VDR binding as important in gene-environment interactions underlying the development of autoimmunity and provides a biological rationale for vitamin D sufficiency being based at 75nmol/L.

Our results also suggest that VDR binding in response to physiological levels of vitamin D occurs predominantly in a VDR motif-independent manner.



Published on: 2013-07-12

Made available by EUPB via SpringerOpen / BioMedCentral. Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. To submit your press release click here.

Discussions




Custom Search



Username
Password










© 2017 7thSpace Interactive
All Rights Reserved - About | Disclaimer | Helpdesk